Kyle Woodley

Kyle Woodley

Senior Investing Editor, Kiplinger

Kyle Woodley is the Senior Investing Editor of Kiplinger.com. His articles covering stock picks, exchange-traded funds and mutual funds have been featured on MSN, Nasdaq and U.S. News & World Report. He also has appeared on Fox Business Network.

He previously was Managing Editor of InvestorPlace.com, and an award-winning designer and copy editor with Gannett. He also is a graduate of Ohio State University.

Kyle can be reached at kwoodley@kiplinger.com, or you can follow him on Twitter at @KyleWoodley.

Recent Articles

50 Blue-Chip Stocks Increasing Dividends in Q1 2013

By Kyle Woodley, Senior Investing Editor, Kiplinger

What's not to love about a big, blue-chip stock that has put its money where its shareholders are with even bigger payouts? These 50 companies did just that in the first quarter of 2013.

Biotech Movers: Peregrine, PharmAthene Climb on Analyst Coverage

By Kyle Woodley, Senior Investing Editor, Kiplinger

Last week in biotech news, Peregrine and PharmAthene both climbed on bullish analyst coverage. Also, find out why Sequenom shed double-digits in one day.

Don’t Dismiss the Ol’ Diamonds

By Kyle Woodley, Senior Investing Editor, Kiplinger

Don't let your financial savvy blind you to the potential for big gains from the DIA exchange-traded fund.

Biotech Movers: Affymax Crashes on Recall

By Kyle Woodley, Senior Investing Editor, Kiplinger

Last week, shares of Affymax got hammered when the company pulled back units of its sole commercial drug. Plus, find out what sent the biggest gainers skyward.

Joe’s Jeans; Or, Why I Love Making Mistakes

By Kyle Woodley, Senior Investing Editor, Kiplinger

Everyone screws up sometimes. The least you can do is learn from the experience.

Load More